Among soft-tissue cancers, this pathogenic variant is found in 12–20% of malignant peripheral nerve sheath tumors and estimated 3.5–13.5% of primary KIT/PDGFRA wild-type gastrointestinal stromal tumors [19, 20]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.